Invention Grant
![Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound](/docs/US/2023-03-07/US11596624B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
-
Application No.: US17248737Application Date: 2021-02-05
-
Publication No.: US11596624B2Publication Date: 2023-03-07
- Inventor: Lori Jean Patterson , Robert S. Chao , Miroslav Rapta
- Applicant: THERAVANCE BIOPHARMA R&D IP, LLC
- Applicant Address: US CA South San Francisco
- Assignee: THERAVANCE BIOPHARMA R&D IP, LLC
- Current Assignee: THERAVANCE BIOPHARMA R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: A61K31/4465
- IPC: A61K31/4465 ; C07D211/22 ; C07D211/32
![Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound](/abs-image/US/2023/03/07/US11596624B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides a crystalline hydrochloride salt of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases.
Public/Granted literature
- US20210290608A1 CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND Public/Granted day:2021-09-23
Information query
IPC分类:
